Fast and slow skeletal troponin I in serum from patients with various skeletal muscle disorders: A pilot study

Jeremy A. Simpson, Ralf Labugger, Christine Collier, Robert J. Brison, Steve Iscoe, Jennifer E. Van Eyk

Research output: Contribution to journalArticle

Abstract

Background: Detection of skeletal muscle injury is hampered by a lack of commercially available assays for serum markers specific for skeletal muscle; serum concentrations of skeletal troponin I (sTnI) could meet this need. Moreover, because sTnI exists in 2 isoforms, slow (ssTnI) and fast (fsTnI), corresponding to slow- and fast-twitch muscles, respectively, it could provide insight into differential injury/recovery of specific fiber types. The purpose of this study was to investigate whether the 2 isoforms of sTnI and their modified forms are present in the blood of patients with various skeletal muscle disorders. Methods: Serial serum samples were obtained from 25 patients with various skeletal muscle injuries. Serum proteins were separated by a modified sodium dodecyl sulfate-polyacrylamide gel electrophoresis protocol followed by Western blotting for sTnI with monoclonal antibodies specific to ssTnI and fsTnI. Results: We observed (a) intact and, in some cases, degraded sTnI products; (b) evidence of posttranslational modifications in addition to proteolysis; and (c) differential detectability of both skeletal isoforms in the same patient. Conclusions: It is possible to monitor both sTnI isoforms; this could lead to the development of new diagnostic assays for skeletal muscle damage.

Original languageEnglish (US)
Pages (from-to)966-972
Number of pages7
JournalClinical chemistry
Volume51
Issue number6
DOIs
StatePublished - Jun 1 2005

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical

Fingerprint Dive into the research topics of 'Fast and slow skeletal troponin I in serum from patients with various skeletal muscle disorders: A pilot study'. Together they form a unique fingerprint.

Cite this